Special problems in toxicity testing of long acting depot contraceptives.
D000230:Adenocarcinoma / Q000139:chemically induced; D000232:Adenofibroma / Q000139:chemically induced; D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D003276:Contraceptives, Oral / Q000633:toxicity*; D006224:Cricetinae; D003692:Delayed-Action Preparations; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004967:Estrogens / Q000494:pharmacology / Q000633:toxicity*; D005260:Female; D005350:Fibroma / Q000139:chemically induced; D000882:Haplorhini; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D010911:Pituitary Neoplasms / Q000139:chemically induced; D011247:Pregnancy; D011372:Progestins / Q000494:pharmacology; D011817:Rabbits; D051381:Rats
D003276:Contraceptives, Oral; D003692:Delayed-Action Preparations; D004967:Estrogens; D011372:Progestins